Skip to main content

Table 4 Relative percentage of NEFA in serum

From: Fasting enriches liver triacylglycerol with n-3 polyunsaturated fatty acids: implications for understanding the adipose–liver axis in serum docosahexaenoic acid regulation

Fatty acid

Ad libitum

Fasted

Serum NEFA (% weight total fatty acids)

C 10:0

0.01 ± 0.02

0.01 ± 0.01

C 12:0

0.39 ± 0.35

0.30 ± 0.24

C 14:0

2.15 ± 0.62

1.98 ± 0.40

C 16:0

26.6 ± 1.77

24.5 ± 3.01

C 18:0

12.45 ± 0.93

10.51 ± 3.43

C 20:0

0.29 ± 0.08

0.28 ± 0.15

C 22:0

0.16 ± 0.03

0.15 ± 0.10

C 23:0

0.05 ± 0.04

0.03 ± 0.02

C 24:0

0.10 ± 0.04

0.15 ± 0.12

Total SFAs

42.2 ± 1.86

37.9 ± 5.87

C 14:1

0.16 ± 0.09

0.22 ± 0.20

C 16:1

6.22 ± 2.96

5.07 ± 1.57

C 18:1n-7

1.99 ± 0.34

1.91 ± 0.26

C 18:1n-9

21.1 ± 2.10

25.14 ± 3.40

C 20:1n-9

0.43 ± 0.05

0.51 ± 0.05*

C 22:1n-9

0.43 ± 0.13

0.41 ± 0.19

C 24:1n-9

0.11 ± 0.10

0.05 ± 0.03

Total MUFAs

30.44 ± 5.12

33.3 ± 4.87

C 18:2n-6

14.26 ± 4.08

17.12 ± 5.26

C 18:3n-6

0.17 ± 0.13

0.21 ± 0.04

C 20:2n-6

0.26 ± 0.08

0.22 ± 0.09

C 20:3n-6

0.38 ± 0.13

0.29 ± 0.24

C 20:4n-6

2.88 ± 1.29

2.63 ± 0.53

C 22:2n-6

0.14 ± 0.04

0.11 ± 0.06

C 22:4n-6

0.20 ± 0.09

0.22 ± 0.05

C 22:5n-6

0.36 ± 0.05

0.17 ± 0.10*

Total n-6

18.65 ± 5.53

20.98 ± 4.84

C 18:3n-3

0.97 ± 0.40

0.87 ± 0.43

C 20:3n-3

0.10 ± 0.02

0.04 ± 0.04*

C 20:5n-3

0.24 ± 0.14

0.14 ± 0.03

C 22:5n-3

0.22 ± 0.17

0.16 ± 0.04

C 22:6n-3

1.71 ± 0.84

1.50 ± 0.17

Total n-3

3.24 ± 1.55

2.71 ± 0.50

n-6/n-3

6.33 ± 1.60

7.75 ± 1.23

Total (μg/mg tissue)

47.24 ± 16.3

55.43 ± 12.59

  1. Data are mean ± SD (n = 3–4)
  2. Significant differences between ad libitum fed and fasted mice are denoted by * p < 0.05